Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Spinal Cord Injury ll: Pathophysiology01:14

Spinal Cord Injury ll: Pathophysiology

Spinal cord injury progresses through two interconnected phases: primary injury and secondary injury.Primary InjuryPrimary injury happens at the moment of trauma and involves immediate mechanical damage to the spinal cord.Compression happens when broken vertebrae, herniated discs, or accumulating blood (such as a hematoma) press directly against the spinal cord, distorting its normal shape and function. In cases of contusion, the cord is bruised by a blunt force (like penetrating injuries or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bone Fusion in the Cervical Spine: Where Are We Now?

Bioengineering (Basel, Switzerland)·2026
Same author

Harnessing Hydrogel Interaction with Functional Polymeric Nanoparticles for Sustained Co-Delivery of Therapeutics.

ACS biomaterials science & engineering·2026
Same author

Hydrogels for the treatment of spinal cord injury: progress and promise.

Nanomedicine (London, England)·2026
Same author

Stromal Vascular Fraction Across Different Clinical Indications: A Pro-Regenerative <i>Fil Rouge</i>.

Journal of clinical medicine·2026
Same author

Rational design of microfluidic templated HA-LPEI nanogels for the targeted delivery of doxorubicin.

Journal of materials chemistry. B·2026
Same author

New Insight in Pediatric Orthopedic Oncology: The Use of a Xeno-Hybrid Bone Substitute in Loss of Bone Tissue After Oncological Resections, a Case Series.

Journal of clinical medicine·2026

Related Experiment Video

Updated: Jun 20, 2026

Promotion of Survival and Differentiation of Neural Stem Cells with Fibrin and Growth Factor Cocktails after Severe Spinal Cord Injury
09:56

Promotion of Survival and Differentiation of Neural Stem Cells with Fibrin and Growth Factor Cocktails after Severe Spinal Cord Injury

Published on: July 27, 2014

12.5K

Biomaterial-Mediated Factor Delivery for Spinal Cord Injury Treatment.

Filippo Pinelli1, Fabio Pizzetti1, Valeria Veneruso2

  • 1Department of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milano, Via Mancinelli 7, 20131 Milan, Italy.

Biomedicines
|July 27, 2022
PubMed
Summary

Spinal cord injury (SCI) treatment requires addressing multiple factors due to its complex, multifactorial nature. Combinatorial strategies using biomaterials offer a promising multitarget approach for neural regeneration and recovery.

Keywords:
hydrogelsinflammationnanoparticlesregenerationspinal cord

More Related Videos

Experimental Strategies to Bridge Large Tissue Gaps in the Injured Spinal Cord after Acute and Chronic Lesion
09:14

Experimental Strategies to Bridge Large Tissue Gaps in the Injured Spinal Cord after Acute and Chronic Lesion

Published on: April 5, 2016

9.1K
Transplantation of Schwann Cells Inside PVDF-TrFE Conduits to Bridge Transected Rat Spinal Cord Stumps to Promote Axon Regeneration Across the Gap
08:05

Transplantation of Schwann Cells Inside PVDF-TrFE Conduits to Bridge Transected Rat Spinal Cord Stumps to Promote Axon Regeneration Across the Gap

Published on: November 3, 2017

7.1K

Related Experiment Videos

Last Updated: Jun 20, 2026

Promotion of Survival and Differentiation of Neural Stem Cells with Fibrin and Growth Factor Cocktails after Severe Spinal Cord Injury
09:56

Promotion of Survival and Differentiation of Neural Stem Cells with Fibrin and Growth Factor Cocktails after Severe Spinal Cord Injury

Published on: July 27, 2014

12.5K
Experimental Strategies to Bridge Large Tissue Gaps in the Injured Spinal Cord after Acute and Chronic Lesion
09:14

Experimental Strategies to Bridge Large Tissue Gaps in the Injured Spinal Cord after Acute and Chronic Lesion

Published on: April 5, 2016

9.1K
Transplantation of Schwann Cells Inside PVDF-TrFE Conduits to Bridge Transected Rat Spinal Cord Stumps to Promote Axon Regeneration Across the Gap
08:05

Transplantation of Schwann Cells Inside PVDF-TrFE Conduits to Bridge Transected Rat Spinal Cord Stumps to Promote Axon Regeneration Across the Gap

Published on: November 3, 2017

7.1K

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Biomaterials Science

Background:

  • Spinal cord injury (SCI) involves acute trauma followed by progressive tissue damage in the subacute phase, leading to neural degeneration.
  • Existing therapeutic interventions for SCI have shown limited clinical success due to the multifactorial nature of the injury.
  • Addressing only single pathological factors is insufficient to halt neural degeneration and paralysis post-SCI.

Purpose of the Study:

  • To review current single and combinatorial regenerative treatments for spinal cord injury.
  • To explore potential biomaterial-based delivery options for multitargeted SCI therapies.
  • To highlight the need for comprehensive strategies in managing SCI pathogenesis.

Main Methods:

  • Literature review of single-factor and combinatorial regenerative treatments for SCI.
  • Analysis of biomaterial applications for in situ drug/biomolecule delivery.
  • Examination of therapeutic approaches targeting multiple neurodegenerative mechanisms.

Main Results:

  • Single-factor treatments have yielded limited success in clinical settings for SCI.
  • Combinatorial strategies utilizing biomaterials show potential for maximized multitargeting.
  • Various regenerative factors and delivery systems are being investigated for SCI treatment.

Conclusions:

  • Effective SCI treatment necessitates a multitargeted approach addressing the multifactorial pathogenesis.
  • Biomaterial-based combinatorial therapies represent a promising avenue for enhancing neural regeneration.
  • Further research into optimized delivery systems is crucial for advancing SCI clinical outcomes.